Overview In August 2021 Belgium's Pharmaceutical products exports accounted up to €6.08B and imports accounted up to €2.47B, resulting in a positive trade balance of €3.6B. Between August 2020 and August 2021 the exports of Belgium's Pharmaceutical products have increased by €3.61B (146%) from €2.47B to €6.08B, while imports increased by €328M (15.3%) from €2.14B to €2.47B.
Destinations In August 2021, Pharmaceutical products were exported mostly to United States (€1.16B), Germany (€1.12B), Japan (€726M), United Kingdom (€464M), and South Korea (€204M), and were imported mostly from Ireland (€496M), Italy (€462M), Switzerland (€379M), United States (€364M), and Germany (€203M).
Growth In August 2021, the increase in Pharmaceutical products's year-by-year exports was explained primarily by an increase in exports to Germany (€813M or 263%), Japan (€692M or 2.03k%), and United States (€576M or 98%). In August 2021, the increase in Pharmaceutical products's year-by-year imports was explained primarily by an increase in imports from Italy (€190M or 70%), United States (€132M or 57.1%), and South Africa (€39.8M or 139k%).